Skip to main content
Premium Trial:

Request an Annual Quote

Personalis Neoantigen Discovery Report

Personalis has launched the Neoantigen Discovery Report for the company's ACE ImmunoID service. The report predicts peptides which can be generated from each expressed somatic variant and then characterizes those by predicting MHC Class I and II binding affinities based on the patient's HLA alleles, and to both self and known antigens. It combines best-in-class and proprietary tools to aide in the rapid evaluation and prioritization of samples and peptides based on a client's needs, the company said.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.